Folgen
Keine Story von Hovione mehr verpassen.
Filtern
  • 17.03.2021 – 15:30

    Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction

    Cork, Ireland (ots/PRNewswire) - Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused by Meibomian Gland Dysfunction (MGD). The well controlled and representative study was conducted across 26 ...

  • 23.09.2020 – 14:52

    Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19

    Lisbon, Portugal (ots/PRNewswire) - Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®. Captisol®, a Ligand product, is a chemically modified cyclodextrin proven to improve the solubility and stability of drugs. It is used in the formulation of Gilead's COVID-19 treatment Veklury® ...

  • 04.05.2020 – 11:45

    Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer

    Loures, Portugal (ots/PRNewswire) - Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020. Dr. Herbeaux held, over the past 20 years, multiple high-level leadership positions at Evonik, bringing to Hovione a proven commitment to develop a successful and globally active business. Based in Lisbon, ...

  • 25.01.2019 – 15:32

    Hovione Issues $50 Million Bond

    Lisbon (ots/PRNewswire) - Hovione has issued a bond of $50 million US dollars maturing in 2033. (Logo: https://mma.prnewswire.com/media/813604/Hovione_Logo.jpg ) The bond was arranged and subscribed by Banco BPI, S.A.. According to António Almeida, Hovione's CFO, "we issued this bond to strengthen our balance sheet as we embark in a new phase of significant capital expansion. We issued a USD denominated bond because the majority of our sales is in the USA". The bond is ...

  • 17.10.2018 – 17:36

    Hovione Increases Production Capacity

    Loures, Portugal (ots/PRNewswire) - 'One Site Shop' expands to respond to growing demands Hovione announces plan to increase production capacity in oral dosage forms in Portugal, to strengthen the integrated offering. New commercial scale equipment for blending, tableting and coating will complement existing development small scale equipment. This decision to expand follows growing customer demand since, one year ago ...

  • 24.01.2018 – 15:31

    Hovione Strengthens Inhalation Services Portfolio

    Loures, Portugal (ots/PRNewswire) - Hovione announced that a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities. This investment reinforces Hovione's Services portfolio in inhalation product development capabilities (http://www.hovione.com/products-and-services/contract-manufacturing-services/drug-product/innovation-and-expertise), which include proprietary particle engineering ...